RESÚMENES JUNIO 2009

.

Mood - Anxiety Disorders & Antidepressants – Mood Stabilizers

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

GRATIS = Texto gratuito en algunos países de la región iberoamericana (algunos artículos requieren ir a la tabla de contenidos del número actual de la revista)

 

3! - Antidepressant-induced jitteriness/anxiety syndrome: systematic review

Lindsey I. Sinclair, David M. Christmas, Sean D. Hood, John P. Potokar, Andrea Robertson, Andrew Isaac, Shrikant Srivastava, David J. Nutt, Simon J. C. Davies

The British Journal of Psychiatry (2009) 194: 483-490

 

GRATIS 3! - Effect of a single dose of citalopram on amygdala response to emotional faces

Susannah E. Murphy, Raymond Norbury, Ursula O'Sullivan, Philip J. Cowen, Catherine J. Harmer

The British Journal of Psychiatry (2009) 194: 535-540

 

3 - Age at onset of first episode and time to treatment in in-patients with bipolar disorder

Gunnar Morken, Arne E. Vaaler, and Gunn E. Folden, Ole A. Andreassen, Ulrik F. Malt

The British Journal of Psychiatry (2009) 194: 559-560

 

5< - Mirtazapine and paroxetine in major depression: A comparison of monotherapy versus their combination from treatment initiation




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Pierre Blier, Gabriella Gobbi, Julie E. Turcotte, Claude de Montigny, Nathalie Boucher, Chantal Hébert and Guy Debonnel

European Neuropsychopharmacology. Volume 19, Issue 7, July 2009, Pages 457-465

 

4 - Pindolol augmentation enhances response outcomes in first depressive episodes




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Maria J. Portella, Javier de Diego-Adeliño, Dolors Puigdemont, Rosario Pérez-Egea, Enric Álvarez, Francesc Artigas and Víctor Pérez

European Neuropsychopharmacology. Volume 19, Issue 7, July 2009, Pages 516-519

 

3! - Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Matthew S. Milak, Ramin V. Parsey, Leilani Lee, Maria A. Oquendo, Doreen M. Olvet, Francoise Eipper, Kevin Malone and J. John Mann

Psychiatry Research: Neuroimaging. Volume 173, Issue 1, 15 July 2009, Pages 63-70

 

3! - Increased subgenual prefrontal cortex size in remitted patients with major depressive disorder




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Kaan Yucel, Margaret McKinnon, Ramandeep Chahal, Valerie Taylor, Kathryn Macdonald, Russell Joffe and Glenda MacQueen

Psychiatry Research: Neuroimaging. Volume 173, Issue 1, 15 July 2009, Pages 71-76

 

3! - Depressive symptoms and metabolic risk: Effects of cortisol and gender




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Christoph Muhtz, Birgit-Christiane Zyriax, Tilman Klähn, Eberhard Windler and Christian Otte

Psychoneuroendocrinology. Volume 34, Issue 7, August 2009, Pages 1004-1011

 

3 - Selective changes in sensitivity to benzodiazepines, and not other positive GABAA modulators, in rats receiving flunitrazepam chronically

Original Investigation

Selective changes in sensitivity to benzodiazepines, and not other positive GABAA modulators, in rats receiving flunitrazepam chronically

Lisa R. Gerak

Psychopharmacology. Volume 204, Number 4 / July, 2009: 667-677

 

3! - Major Depressive Disorder and Hypothalamic-Pituitary-Adrenal Axis Activity. Results From a Large Cohort Study

Sophie A. Vreeburg, Witte J. G. Hoogendijk, Johannes van Pelt, Roel H. DeRijk, Jolanda C. M. Verhagen, Richard van Dyck, Johannes H. Smit, Frans G. Zitman, MDBrenda W. J. H. Penninx

Arch Gen Psychiatry. 2009;66(6):617-626

 

3! - Persisting Decline in Depression Treatment After FDA Warnings

Anne M. Libby, Heather D. Orton, Robert J. Valuck

Arch Gen Psychiatry. 2009;66(6):633-639

 

GRATIS 3 - Epidemiologic heterogeneity of common mood and anxiety disorders over the lifecourse in the general population: a systematic review

Arijit Nandi, John R Beard and Sandro Galea

BMC Psychiatry 2009, 9:31

 

3 - Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis

Ioannis Tsiropoulos, Morten Andersen, Jesper Hallas

Pharmacoepidemiology and Drug Safety. Volume 18 Issue 6, Pages 483 - 491

 

3 - An increased risk of road traffic accidents after prescriptions of lithium or valproate?

Jørgen G. Bramness, Svetlana Skurtveit, C. Ineke Neutel, Jørg Mørland, Anders Engeland

Pharmacoepidemiology and Drug Safety. Volume 18 Issue 6, Pages 492 - 496

 

3 - The history of lithium therapy

Edward Shorter

Bipolar Disorders. Volume 11 Issue s2, Pages 4 - 9

 

3 - A critical appraisal of lithium's efficacy and effectiveness: the last 60 years

Paul Grof and Bruno Müller-Oerlinghausen

Bipolar Disorders. Volume 11 Issue s2, Pages 10 - 19

 

3 - Anticonvulsants in bipolar disorders: current research and practice and future directions

Charles L Bowden

Bipolar Disorders. Volume 11 Issue s2, Pages 20 - 33

 

3 - Lithium specificity in bipolar illness: a classic agent for the classic disorder

Samuel Gershon, KN Roy Chengappa and Gin S Malhi

Bipolar Disorders. Volume 11 Issue s2, Pages 34 - 44

 

3 - Antipsychotic agents in the treatment of bipolar mania

Mauricio Tohen and Eduard Vieta

Bipolar Disorders. Volume 11 Issue s2, Pages 45 - 54

 

3 - Medicating mood with maintenance in mind: bipolar depression pharmacotherapy

Gin S Malhi, Danielle Adams and Michael Berk

Bipolar Disorders. Volume 11 Issue s2, Pages 55 - 76

 

3 - Maintenance treatment in bipolar disorder: a reassessment of lithium as the first choice

William Coryell

Bipolar Disorders. Volume 11 Issue s2, Pages 77 - 83

 

3 - The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis

Rodrigo Machado-Vieira, Husseini K Manji and Carlos A Zarate Jr

Bipolar Disorders. Volume 11 Issue s2, Pages 92 - 109

 

3 - Inflammation and the Phenomenology, Pathophysiology, Comorbidity, and Treatment of Bipolar Disorder: A Systematic Review of the Literature

Benjamin I. Goldstein, David E. Kemp, Joanna K. Soczynska, and Roger S. McIntyre

J Clin Psychiatry June 2, 2009: e1-e13

 

3 - Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy

Alwan, Sura; Friedman, Jan M

CNS Drugs. 23(6):493-509, May 30, 2009

3 - Duloxetine: A Review of its Use in the Treatment of Generalized Anxiety Disorder

Carter, Natalie J.; McCormack, Paul L

CNS Drugs. 23(6):523-541, May 30, 2009

3! - Mechanisms of gene–environment interactions in depression: evidence that genes potentiate multiple sources of adversity

M. Wichers, D. Schrijvers, N. Geschwind, N. Jacobs, I. Myin-Germeys, E. Thiery, C. Derom, B. Sabbe, F. Peeters, Ph. Delespaul and J. van Os

Psychological Medicine (2009), 39:1077-1086

 

3! - Interaction between the 5-HTTLPR serotonin transporter polymorphism and environmental adversity for mood and anxiety psychopathology: evidence from a high-risk community sample of young adults

Manfred Laucht, Jens Treutlein, Dorothea Blomeyer, Arlette F. Buchmann, Brigitte Schmid, Katja Becker, Ulrich S. Zimmermann, Martin H. Schmidt, Günter Esser, Marcella Rietschel and Tobias Banaschewski

The International Journal of Neuropsychopharmacology, Volume 12, Issue 06, July 2009, pp 737-747

 

5 - Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression

Eileen Brown, David L. Dunner, Susan L. McElroy, Paul E. Keck, David H. Adams, Elisabeth Degenhardt, Mauricio Tohen and John P. Houston

The International Journal of Neuropsychopharmacology, Volume 12, Issue 06, July 2009, pp 773-782

 

3 - Enhancement of cortical extracellular 5-HT by 5-HT1A and 5-HT2C receptor blockade restores the antidepressant-like effect of citalopram in non-responder mice

Eleonora Calcagno, Sara Guzzetti, Alessandro Canetta, Claudia Fracasso, Silvio Caccia, Luigi Cervo and Roberto W. Invernizzi

The International Journal of Neuropsychopharmacology, Volume 12, Issue 06, July 2009, pp 793-803

 

3! - Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamine-induced mitochondrial damage

Rosilla F. Bachmann, Yun Wang, Peixiong Yuan, Rulun Zhou, Xiaoxia Li, Salvatore Alesci, Jing Du and Husseini K. Manji

The International Journal of Neuropsychopharmacology, Volume 12, Issue 06, July 2009, pp 805-822

 

3! - Relevance of dorsal raphe nucleus firing in serotonin 5-HT2C receptor blockade-induced augmentation of SSRIs effects




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Florence Sotty, Joost H.A. Folgering, Lise T. Brennum, Sandra Hogg, Arne Mørk, Peter Hertel and Thomas I.F.H. Cremers

Neuropharmacology. Volume 57, Issue 1, July 2009, Pages 18-24

 

3 - Effects of the histone deacetylase inhibitor sodium butyrate in models of depression and anxiety




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Brigitta B. Gundersen and Julie A. Blendy

Neuropharmacology. Volume 57, Issue 1, July 2009, Pages 67-74

 

3! - Co-Treatment with Diazepam Prevents the Effects of Fluoxetine on the Proliferation and Survival of Hippocampal Dentate Granule Cells




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Xuefei Wu and Eero Castrén

Biological Psychiatry. Volume 66, Issue 1, 1 July 2009, Pages 5-8

GRATIS 3! - Management of obsessive-compulsive disorder with fluvoxamine extended release

Lídia Ordacgi, Mauro V Mendlowicz, Leonardo F Fontenelle

Neuropsychiatric Disease and Treatment. Published Date May 2009

 

4! - Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies

M. A. Frye, L. Yatham, T. A. Ketter, J. Goldberg, T. Suppes, J. R. Calabrese, C. L. Bowden, E. Bourne, R. S. Bahn, B. Adams

Acta Psychiatrica Scandinavica. Volume 120 Issue 1, Pages 10 - 13

 

3! - No association of depression and anxiety with the metabolic syndrome: the Norwegian HUNT study

B. Hildrum, A. Mykletun, K. Midthjell, K. Ismail, A. A. Dahl

Acta Psychiatrica Scandinavica. Volume 120 Issue 1, Pages 14 - 22

 

3! - Association of depressive symptoms and metabolic syndrome in men

H. Viinamäki, T. Heiskanen, S. M. Lehto, L. Niskanen, H. Koivumaa-Honkanen, T. Tolmunen, K. Honkalampi, T. Saharinen, K. Haatainen, J. Hintikka

Acta Psychiatrica Scandinavica. Volume 120 Issue 1, Pages 23 - 29

 

3! - Atypical depression is associated with suicide attempt in bipolar disorder

V. Sánchez-Gistau, F. Colom, A. Mané, S. Romero, G. Sugranyes, E. Vieta

Acta Psychiatrica Scandinavica. Volume 120 Issue 1, Pages 30 - 36

 

3! - Decrease in suicide among the individuals treated with antidepressants: a controlled study of antidepressants in suicide, Sweden 1995–2005

G. Isacsson, A. Holmgren, U. Ösby, J. Ahlner

Acta Psychiatrica Scandinavica. Volume 120 Issue 1, Pages 37 - 44

 

3 - Brain-derived neurotrophic factor gene polymorphisms and mirtazapine responses in Koreans with major depression

RH Kang, HS Chang, ML Wong, MJ Choi, JY Park, HY Lee, IK Jung, SH Joe, L Kim, SH Kim, YK Kim, CS Han, BJ Ham, HJ Lee, YH Ko, MS Lee, and MS Lee

Journal of Psychopharmacology First published on June 3, 2009

4 - Comparison of Propofol and Thiopental as Anesthetic Agents for Electroconvulsive Therapy: A Randomized, Blinded Comparison of Seizure Duration, Stimulus Charge, Clinical Effect, and Cognitive Side Effects

Bauer, Jeanett; Hageman, Ida; Dam, Henrik; Báez, Armando; Bolwig, Tom; Roed, Jakob; Olsen, Niels Vidiendal; Jørgensen, Martin Balslev

The Journal of ECT: June 2009 - Volume 25 - Issue 2 - pp 85-90

 

3 - Differential Patterns of HPA Activity and Reactivity in Adult Posttraumatic Stress Disorder and Major Depressive Disorder

Kathryn Handwerger

Harvard Review of Psychiatry, Volume 17, Issue 3 June 2009, pages 184 - 205

 

3 - The Bipolar Spectrum: A Critical Perspective

Joel Paris

Harvard Review of Psychiatry, Volume 17, Issue 3 June 2009, pages 206 - 213

 

3! - Management issues for women with epilepsy—Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes

Cynthia L. Harden, Kimford J. Meador, Page B. Pennell, W. Allen Hauser, Gary S. Gronseth, Jacqueline A. French, Samuel Wiebe, David Thurman, Barbara S. Koppel, Peter W. Kaplan, Julian N. Robinson, Jennifer Hopp, Tricia Y. Ting, Barry Gidal, Collin A. Hovinga, Andrew N. Wilner, Blanca Vazquez, Lewis Holmes, Allan Krumholz, Richard Finnell, Deborah Hirtz, and Claire Le Guen

Epilepsia. Volume 50 Issue 5, Pages 1237 - 1246

 

3 - Genetic and pharmacokinetic factors affecting the initial pharmacotherapeutic effect of paroxetine in Japanese patients with panic disorder

Pharmacogenetics

Genetic and pharmacokinetic factors affecting the initial pharmacotherapeutic effect of paroxetine in Japanese patients with panic disorder

Yoshinori Saeki, Takashi Watanabe, Mikito Ueda, Atsushi Saito, Kazufumi Akiyama, Yoshimasa Inoue, Genta Hirokane, Sachiyo Morita, Naoto Yamada and Kazutaka Shimoda

European Journal of Clinical Pharmacology. Volume 65, Number 7 / julio de 2009: 685-691

 

3 - Effect of smoking and CYP2D6 polymorphisms on the extent of fluvoxaminealprazolam interaction in patients with psychosomatic disease

Pharmacokinectics and Disposition

Effect of smoking and CYP2D6 polymorphisms on the extent of fluvoxamine–alprazolam interaction in patients with psychosomatic disease

Hideyo Sugahara, Chiharu Maebara, Hisakazu Ohtani, Masanori Handa, Katsumi Ando, Kazunori Mine, Chiharu Kubo, Ichiro Ieiri and Yasufumi Sawada

European Journal of Clinical Pharmacology. Volume 65, Number 7 / julio de 2009: 699-704

 

3! - Antidepressant use and mortality in Finland: a register-linkage study from a nationwide cohort

Pharmacoepidemiology and Prescription

Antidepressant use and mortality in Finland: a register-linkage study from a nationwide cohort

Jari Haukka, Martti Arffman, Timo Partonen, Sinikka Sihvo, Marko Elovainio, Jari Tiihonen, Jouko Lönnqvist and Ilmo Keskimäki

European Journal of Clinical Pharmacology. Volume 65, Number 7 / julio de 2009: 715-720

 

3 - The Effect of Psychotherapy Added to Pharmacotherapy on Cortisol Responses in Outpatients With Major Depressive Disorder

Yang, Tsung-Tsair; Hsiao, Fei-Hsiu; Wang, Kuo-Chang; Ng, Siu-Man; Ho, Rainbow T. H; Chan, Cecilia L. W; Lai, Yu-Ming; Chen, Yu-Ting

The Journal of Nervous and Mental Disease: June 2009 - Volume 197 - Issue 6 - pp 401-406

 

3 - The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression

Pharmacodynamics

The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression

Esra Küçükibrahimoğlu, Melek Z. Saygın, Mecit Çalışkan, Okan K. Kaplan, Cüneyt Ünsal and M. Zafer Gören

European Journal of Clinical Pharmacology. Volume 65, Number 6 / junio de 2009: 571-577

 

3 - A proteomic investigation of similarities between conventional and herbal antidepressant treatments

K Pennington, M Föcking, CA McManus, CM Pariante, MJ Dunn, DR Cotter

Journal of Psychopharmacology, Vol. 23, No. 5, 520-530 (2009)

5< - Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR

K Hewett, W Chrzanowski, M Schmitz, A Savela, V Milanova, M Gee, A Krishen, L Millen, MO Leary, J Modell

Journal of Psychopharmacology, Vol. 23, No. 5, 531-538 (2009)

5 - Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-analysis

IM Omori, N Watanabe, A Nakagawa, T Akechi, A Cipriani, C Barbui, H McGuire, R Churchill, TA Furukawa

Journal of Psychopharmacology, Vol. 23, No. 5, 539-550 (2009)

3! - Normalisation of immune cell imbalance after pharmacological treatments of patients suffering from obsessive-compulsive disorder

D Marazziti, F Mungai, I Masala, S Baroni, L Vivarelli, F Ambrogi,M Catena Dell’Osso, G Consoli, G Massimetti, L Dell’Osso

Journal of Psychopharmacology, Vol. 23, No. 5, 567-573 (2009)

5 - Pharmacological interventions for the prevention of relapse in bipolar disorder: a systematic review of controlled trials

S Beynon, K Soares-Weiser, N Woolacott, S Duffy, JR Geddes

Journal of Psychopharmacology, Vol. 23, No. 5, 574-591 (2009)

3! - Interaction Between the Serotonin Transporter Gene (5-HTTLPR), Stressful Life Events, and Risk of Depression. A Meta-analysis

Neil Risch, Richard Herrell, Thomas Lehner, Kung-Yee Liang, Lindon Eaves, Josephine Hoh, Andrea Griem, Maria Kovacs, Jurg Ott, Kathleen Ries Merikangas

JAMA. 2009;301(23):2462-2471

 

3! - Cutaneous Adverse Reactions to Psychotropic Drugs: Data From a Multicenter Surveillance Program

Christian Lange-Asschenfeldt, Renate Grohmann, Bernhard Lange-Asschenfeldt, Rolf R. Engel, Eckart Rüther, and Joachim Cordes

J Clin Psychiatry June 16, 2009: e1-e8

 

GRATIS 3 - Persistence and compliance to antidepressant treatment in patients with depression: A chart review

Norifusa Sawada, Hiroyuki Uchida, Takefumi Suzuki, Koichiro Watanabe, Toshiaki Kikuchi, Takashi Handa and Haruo Kashima

BMC Psychiatry 2009, 9:38

 

3 - A multistage chronobiologic intervention for the treatment of depression: A pilot study




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Lucian Moscovici and Moshe Kotler

Journal of Affective Disorders. Volume 116, Issue 3, August 2009, Pages 201-207

 

3! - Imipramine Treatment and Resiliency Exhibit Similar Chromatin Regulation in the Mouse Nucleus Accumbens in Depression Models

Matthew B. Wilkinson, Guanghua Xiao, Arvind Kumar, Quincey LaPlant, William Renthal, Devanjan Sikder, Thomas J. Kodadek, and Eric J. Nestler

The Journal of Neuroscience, June 17, 2009, 29(24):7820-7832

 

3 - Is it always the same? Variability of depressive symptoms across six European countries




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Sebastian Bernert, Herbert Matschinger, Jordi Alonso, Josep Maria Haro, Traolach S. Brugha, Matthias C. Angermeyer and the ESEMeD / MHEDEA 2000 investigators

Psychiatry Research. Volume 168, Issue 2, 30 July 2009, Pages 137-144

 

3 - Neurobiology of repeated transcranial magnetic stimulation in the treatment of anxiety: a critical review

Pallanti, Stefano; Bernardi, Silvia

International Clinical Psychopharmacology: July 2009 - Volume 24 - Issue 4 - pp 163-173

 

3! - The efficacy of pregabalin and benzodiazepines in generalized anxiety disorder presenting with high levels of insomnia

Montgomery, Stuart A; Herman, Barry K; Schweizer, Edward; Mandel, Francine S

International Clinical Psychopharmacology: July 2009 - Volume 24 - Issue 4 - pp 214-222

 

3! - Reducing Suicidal Ideation and Depression in Older Primary Care Patients: 24-Month Outcomes of the PROSPECT Study

George S. Alexopoulos, Charles F. Reynolds III, Martha L. Bruce, Ira R. Katz, Patrick J. Raue, Benoit H. Mulsant, David W. Oslin, Thomas Ten Have, and The PROSPECT Group

Am J Psychiatry Published June 15, 2009

3 - Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep–wake cycle architecture

Original Investigation

Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep–wake cycle architecture

Amandine Descamps, Colette Rousset, Mark Millan, Michael Spedding, Philippe Delagrange and Raymond Cespuglio

Psychopharmacology. Volume 205, Number 1 / julio de 2009: 93-106

 

3! - Antidepressant response to electroconvulsive therapy is sustained after catecholamine depletion




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Frederick Cassidy, Richard D. Weiner, Thomas B. Cooper and Bernard J. Carroll

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 33, Issue 5, 1 August 2009, Pages 872-874

3! - Glutamate as a spectroscopic marker of hippocampal structural plasticity is elevated in long-term euthymic bipolar patients on chronic lithium therapy and correlates inversely with diurnal cortisol

Colla, F Schubert, M Bubner, J O Heidenreich, M Bajbouj, F Seifert, A Luborzewski, I Heuser and G Kronenberg

Molecular Psychiatry (2009) 14, 696–704

 

3 - Regional distribution of clomipramine and desmethylclomipramine in rat brain and peripheral organs on chronic clomipramine administration

K Aitchison, K Datla, H Rooprai, J Fernando, and D Dexter

Journal of Psychopharmacology First published on June 24, 2009

3! - Treatment of depression in the elderly: A review of the recent literature on the efficacy of single- versus dual-action antidepressants




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Yuki Mukai and Rajesh R. Tampi

Clinical Therapeutics. Volume 31, Issue 5, May 2009, Pages 945-961

 

3 - Long-Term Safety and Efficacy of Ziprasidone in Subpopulations of Patients With Bipolar Mania

Paul E. Keck, Jr; Marcio Versiani, Lewis Warrington, Antony D. Loebel, and R. Lynn Horne

J Clin Psychiatry 2009;70(6):844-851

 

3 - A Long-Term Trial of the Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder

Hisato Matsunaga, Toshihiko Nagata, Kazuhisa Hayashida, Kenzo Ohya, Nobuo Kiriike, and Dan J. Stein

J Clin Psychiatry 2009;70(6):863-868

 

3 - The Safety, Acceptability, and Effectiveness of Acupuncture as an Adjunctive Treatment for Acute Symptoms in Bipolar Disorder

Ellen B. Dennehy, Rosa Schnyer, Ira H. Bernstein, Robert Gonzalez, Geetha Shivakumar, Dorothy I. Kelly, Diane E. Snow, Suresh Sureddi, and Trisha Suppes

J Clin Psychiatry 2009;70(6):897-905

 

3 - Protein Kinase C Inhibitors: Rationale for Use and Potential in the Treatment of Bipolar Disorder

Zarate, Carlos A; Manji, Husseini K

CNS Drugs. 23(7):569-582, July 7, 2009

3 - Cardiovascular Abnormalities in Patients with Major Depressive Disorder: Autonomic Mechanisms and Implications for Treatment

Brown, Alex D.H; Barton, David A; Lambert, Gavin W

CNS Drugs. 23(7):583-602, July 7, 2009

5 - Relapse rates with long-term antidepressant drug therapy: a meta-analysis

Nolan Williams, Annie N. Simpson, Kit Simpson, Ziad Nahas

Human Psychopharmacology: Clinical and Experimental. Volume 24 Issue 5, Pages 401 - 408

 

GRATIS 3! - Enhancement of the function of rat serotonin and norepinephrine neurons by sustained vagus nerve stimulation

Stella Manta, Jianming Dong, Guy Debonnel, Pierre Blier

J Psychiatry Neurosci 2009;34(4):272-80

 

GRATIS 3! - Estimating the Economic Costs of Antidepressant Discontinuation During Pregnancy

Lisa O’Brien, Audrey Laporte, Gideon Koren

Can J Psychiatry. 2009;54(6):399–408

 

GRATIS 5 - Extended Release Quetiapine Fumarate Monotherapy for Major Depressive Disorder: Results of a Double-Blind, Randomized, Placebo-Controlled Study

Richard Weisler, J. Mark Joyce, Lora McGill, Arthur Lazarus, Johan Szamosi, and Hans Eriksson for the Moonstone Study Group

CNS Spectr. 2009;14(6):299-313

 

GRATIS 4 - Escitalopram Versus SNRI Antidepressants in the Acute Treatment of Major Depressive Disorder: Integrative Analysis of Four Double-Blind, Randomized Clinical Trials

Susan G. Kornstein, Dayong Li, Yongcai Mao, Sara Larsson, Henning F. Andersen, and George I. Papakostas

CNS Spectr. 2009;14(6):326-333

 

GRATIS 3 (previo registro) - Selective Serotonin Reuptake Inhibitor Use During Pregnancy and Possible Neonatal Complications

Jillan Cantor Sackett, Ronald A. Weller, and Elizabeth B. Weller

Current Psychiatry Reports 2009, 11: (3) 253-257

 

GRATIS 3 - Electroconvulsive therapy in major depression: current aspects

ANTUNES, Paula Barros et al.

Rev. Bras. Psiquiatr 2009, vol.31, suppl.1, pp. S26-S33

 

GRATIS 3 - Transcranial direct current stimulation: a promising alternative for the treatment of major depression?

BERLIM, Marcelo T; DIAS NETO, Vitor  and  TURECKI, Gustavo

Rev. Bras. Psiquiatr 2009, vol.31, suppl.1, pp. S34-S38

 

3 - Safety, tolerability and efficacy of a rapid dose escalation of quetiapine in bipolar I mania: the FATIMA study

Eric Constant, Arlette Seghers, Enio Ranalli, Vincent Ryckmans, Phillippe Snauwaert, Marcel Parent, Guy Vandenhoven

Acta Neuropsychiatrica. Volume 21 Issue 3, Pages 125 - 132

.

Regresar a RESÚMENES JUNIO 2009

.

© 1999-2009 Jorge M Tamayo, MD, BMSS

Creada en Enero 1999

Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA.